From Mechanism to Medicine: What Drugs That Reached the Clinic Have in Common — and What Held Others Back

What 2,500+ studies reveal about the relationship between in vivo data quality and translational success – and what it means for the next generation of...

Read more

From Mechanism to Medicine: What Drugs That Reached the Clinic Have in Common — and What Held Others Back

What 2,500+ studies reveal about the relationship between in vivo data quality and translational success – and what it means for the next generation of...

Learn more
PhenoMaster - Polyagonist Therapies in Obesity

Polyagonist Therapies in Obesity: A systems-level case study enabled by continuous in vivo phenotyping

Introduction  Obesity and type 2 diabetes are not single-pathway diseases. They emerge from a complex disruption of whole-body energy homeostasis involving the gut, brain, pancreas,...

Learn more

Autism Awareness Month: Advancing Preclinical Insights with Mouse Models

Autism Spectrum Disorder (ASD) is a multifaceted neurodevelopmental condition characterized by social communication deficits, restricted interests, and repetitive behaviors. While our clinical understanding of ASD...

Learn more

Young Blood May Hold the Key to Reversing Aging

The relentless march of time brings with it a gradual decline in cellular function. This process, known as aging, disrupts the delicate balance within our...

Learn more